Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Humacyte Inc (NQ: HUMA )

8.200 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 118,800
Open 8.200
Bid (Size) 8.310 (10)
Ask (Size) 8.400 (3)
Prev. Close 8.200
Today's Range 8.200 - 8.200
52wk Range 1.960 - 9.970
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Three Small-Cap Stocks to Buy Before a September-Rate-Cut Rally
Discover three small-cap stocks to buy before the Fed acts on interest rates as these small-cap stocks will utilize any cuts to multiply. 
Via InvestorPlace
Topics Economy
Exposures Interest Rates
What's Going On With Huamacyte Shares Tuesday?
Humacyte has so far added Dr. John P. Bamforth and Dr. Keith Anthony to its Board of Directors, entered a license agreement with Pluristyx and received Regenerative Medicine Advanced Therapy (RMAT)... 
Via Benzinga
Exposures Product Safety

Performance

YTD
+183.74%
+183.74%
1 Month
+52.70%
+52.70%
3 Month
+109.18%
+109.18%
6 Month
+157.05%
+157.05%
1 Year
+150.00%
+150.00%

More News

Read More
Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
(HUMA) - Analyzing Humacyte's Short Interest
Via Benzinga
Peering Into Humacyte's Recent Short Interest
Via Benzinga
How Is The Market Feeling About Humacyte?
Via Benzinga
Peering Into Humacyte's Recent Short Interest
Via Benzinga
MicroStrategy, Coinbase, Robinhood, Tesla And Other Big Stocks Moving Higher On Monday
Via Benzinga
Pluristyx Announces License Agreement with Humacyte to Develop BioVascular Pancreas using iPSCs
From Pluristyx
Via Business Wire
Why Humacyte Stock Is Trading 15% Higher Monday
Via Benzinga
Tommy Tuberville Sells Several Large Stock Positions, Makes New Buys: Here's What The US Senator Is Betting On Now
Via Benzinga
HUMA Stock Earnings: Humacyte Meets EPS for Q4 2023
Via InvestorPlace
Earnings Preview: Humacyte
Via Benzinga
AMC Networks, Louisiana-Pacific And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Via Benzinga
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why American Eagle Outfitters Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
HUMA Stock Earnings: Humacyte Misses EPS for Q1 2024
Via InvestorPlace
Why Super Micro Computer Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Fifth Third Bancorp Reports Upbeat Earnings, Joins Metropolitan Bank Holding, Paramount Global And Other Big Stocks Moving Higher On Friday
Via Benzinga
Ally Financial Reports Upbeat Earnings, Joins Badger Meter, Genuine Parts And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Tommy Tuberville Trades Raise Eyebrows Again: Senator Sells Put Options, Buys Small Biotech Linked To Ukraine-Russia War
Via Benzinga
Earnings Scheduled For March 22, 2024
Via Benzinga
Investor Optimism Improves Slightly; Dow Jumps Over 250 Points
Via Benzinga
Topics Stocks
Exposures US Equities
Senator Tommy Tuberville's Latest 2 Stock Trades Attract The Wrong Kind Of Attention: 'Should This Be Allowed?'
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.